The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients

Transplantation
J P BoudreauxD S Fryd

Abstract

The incidence of posttransplant diabetes mellitus (PTDM) was compared in three groups of renal transplant recipients: nondiabetic patients who had been randomized between 1980 and 1983 to receive antilymphoblast globulin (ALG), azathioprine (AZA), and prednisone (P) (group 1) or cyclosporine (CsA) plus prednisone (group 2). Group 3 consisted of a more recent (1984-85) cohort who were given a combination of azathioprine, cyclosporine, and prednisone (+/- ALG). PTDM developed in 20 of 173 previously nondiabetic 18-55-year-old patients. Three of 47 patients (6.4%) in group 1, 4 of 58 patients (6.9%) in group 2, and 13 of 68 patients in group 3 (19.1%) developed PTDM. Thus in the two groups composing the concurrent prospective randomized trial (groups 1 and 2) the incidence of PTDM did not differ. The subsequent patients who were given a combination of ALG, azathioprine, cyclosporine, and prednisone developed a significantly greater incidence of PTDM even though the total dose of cyclosporine and prednisone were lower than in groups 1 and 2. PTDM usually occurred within two months of transplantation, and 11 of 17 patients who initially required insulin are still dependent upon exogenous insulin. The incidence of PTDM was not signif...Continue Reading

Citations

Nov 1, 1990·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·J Mason
Sep 1, 1989·Klinische Wochenschrift·W H HörlH Wilms
Oct 12, 2012·International Urology and Nephrology·Erhan TatarHuseyin Toz
Jan 31, 2004·The Journal of Hand Surgery·Neil F JonesKayvan T Khiabani
Mar 26, 2004·Transplantation Proceedings·B D Maes, Y F Ch Vanrenterghem
Mar 22, 2000·Metabolism: Clinical and Experimental·T KonradP Neuhaus
Aug 11, 2001·Transplantation Proceedings·A V Reisaeter, A Hartmann
Aug 11, 2001·Transplantation Proceedings·J B ChilcottR Moore
Dec 26, 2001·Transplantation Proceedings·M KoseljA Bren
Dec 5, 1998·Transplantation Proceedings·J FangS Chu
Dec 7, 2000·Diabetes Research and Clinical Practice·J H NamK B Huh
Feb 14, 2002·Diabetes Research and Clinical Practice·K V JohnyM Al-Mousawi
Feb 26, 2000·Diabetic Medicine : a Journal of the British Diabetic Association·B DepczynskiA Keogh
Jan 12, 2002·Kidney International·Bertram L Kasiske
Sep 1, 1990·Annals of Surgery·S TodoR Shapiro
Sep 1, 1991·Transplantation·C RicordiT E Starzl
Dec 27, 1996·Transplantation·R ShapiroT E Starzl
Apr 17, 2004·Transplantation·David Baldwin, Karen E Duffin
Aug 24, 2006·Transplantation·Jennifer L LarsenFrederick G Hamel
Dec 17, 2008·Nephrology·Kai Ming Chow, Philip Kam-Tao Li
Sep 10, 2004·BMC Nephrology·Hassan ArganiHamid T Khosroshahi
Apr 4, 2008·Journal of the American Society of Nephrology : JASN·Olwyn JohnstonJohn S Gill
Jul 16, 2011·Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy·Phuong-Thu T PhamPhuong-Chi T Pham
Jan 1, 2010·International Journal of Nephrology and Renovascular Disease·Vadamalai Vivek, Sunil Bhandari
Oct 28, 2006·Drugs & Aging·Alain DuclosStuart M Flechner
Jul 5, 2001·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·B Fellström
Sep 21, 2004·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Sulaiman A Nanji, A M James Shapiro
Mar 7, 2008·Clinical Journal of the American Society of Nephrology : CJASN·Edward H ColeJohn S Gill
Feb 20, 2010·Clinical Journal of the American Society of Nephrology : CJASN·Mads HornumBo Feldt-Rasmussen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Epigenetics Insights from Twin Studies

Find the latest research on epigenetics and twin studies here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Regulation of Vocal-Motor Plasticity

Dopaminergic projections to the basal ganglia and nucleus accumbens shape the learning and plasticity of motivated behaviors across species including the regulation of vocal-motor plasticity and performance in songbirds. Discover the latest research on the regulation of vocal-motor plasticity here.

Myocardial Stunning

Myocardial stunning is a mechanical dysfunction that persists after reperfusion of previously ischemic tissue in the absence of irreversible damage including myocardial necrosis. Here is the latest research.